| TRANSFORMING RADIOTHERAPY Galera Therapeutics, Inc.
90976164 08 Oct 2020 | on 19 Apr 2022
| Research and development in the pharmaceutical and biotechnology field... Class 042 Class 042 Computer & Software Services & Scientific Services "RADIOTHERAPY" | | | Logo Mark Galera Therapeutics, Inc.
97672085 10 Nov 2022 | on 23 Dec 2024
| Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized flower with overlapping petals in light blue, royal blue, green, and pink. | | | Logo Mark Galera Therapeutics, Inc.
97672111 10 Nov 2022 | on 23 Dec 2024
| Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products The mark consists of a stylized flower with overlapping petals. | | | TRANSFORMING RADIATION THERAPY Galera Therapeutics, Inc.
90711834 14 May 2021 | on 16 Dec 2024
| Pharmaceuticals for reducing side effects or improving efficacy for ca... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for reducing side effects or improving efficacy for cancer and oncology patients; pharmaceuticals for the prevention, treatment or management of superoxide mediated conditions; biotechnological preparations for medical use for the treatment of oncological disorders and treatment-related side effects Class 042 Class 042 Computer & Software Services & Scientific Services "RADIATION THERAPY" | | | TRANSFORMING RADIOTHERAPY Galera Therapeutics, Inc.
90242485 08 Oct 2020 | on 15 Jul 2024
| Pharmaceuticals for reducing side effects or improving efficacy for ca... Class 005 Class 005 Pharmaceutical Products "RADIOTHERAPY" | | | IQALZO Galera Therapeutics, Inc.
88705133 25 Nov 2019 | on 12 Feb 2024 | Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection | | | ORDOLVEE Galera Therapeutics, Inc.
88705129 25 Nov 2019 | on 12 Feb 2024 | Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection | | | ELYMUCO Galera Therapeutics, Inc.
88705126 25 Nov 2019 | on 12 Feb 2024 | Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection | | | OMDYMA Galera Therapeutics, Inc.
88705135 25 Nov 2019 | on 12 Feb 2024 | Pharmaceuticals for reducing side effects and improving efficacy in tr... Class 005 Class 005 Pharmaceutical Products Pharmaceuticals for reducing side effects and improving efficacy in treatments for cancer and oncology patients; pharmaceuticals for the prevention, treatment and management of superoxide mediated conditions; biotechnological preparations for medical use being biological preparations for the treatment of cancer, oncological disorders and diseases, neurological disorders and diseases, respiratory disorders and diseases, dermatological disorders and diseases, pulmonary disorders and diseases, degenerative disorders and diseases, immunological disorders and diseases, infectious disorders and diseases, cardiovascular disorders and diseases, and radiation protection | | | Logo Mark Galera Therapeutics, Inc.
97037525 21 Sep 2021 | on 18 Dec 2023 | Pharmaceuticals for reducing side effects or improving efficacy for ca... Class 005 Class 005 Pharmaceutical Products The mark consists of an abstract sword bisecting the divided outline of a shield. Class 042 Class 042 Computer & Software Services & Scientific Services Pharmaceuticals for reducing side effects or improving efficacy for cancer and oncology patients; pharmaceuticals for the prevention, treatment or management of superoxide mediated conditions; biotechnological preparations for medical use for the treatment of oncological disorders and treatment-related side effects | | 
